CRMD vs. PLTR

Last updated Apr 1, 2026

Compare and contrast key facts about CorMedix Inc. (CRMD) and Palantir Technologies Inc. (PLTR).

Performance

CRMD vs. PLTR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CorMedix Inc. (CRMD) and Palantir Technologies Inc. (PLTR). The values are adjusted to include any dividend payments, if applicable.

CRMD vs. PLTR - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
CRMD CorMedix Inc.	-41.62%	43.58%	115.43%	-10.90%	-7.25%	-38.76%	23.22%
PLTR Palantir Technologies Inc.	-17.70%	135.03%	340.48%	167.45%	-64.74%	-22.68%	147.89%

Fundamentals

Market Cap CRMD : $637.71M PLTR : $376.45B
EPS CRMD : $1.94 PLTR : $0.63
PE Ratio CRMD : 3.50 PLTR : 231.01
PS Ratio CRMD : 1.83 PLTR : 83.88
PB Ratio CRMD : 1.57 PLTR : 50.96
Total Revenue (TTM) CRMD : $311.71M PLTR : $4.48B
Gross Profit (TTM) CRMD : $275.75M PLTR : $3.69B
EBITDA (TTM) CRMD : $157.78M PLTR : $1.52B

Returns By Period

In the year-to-date period, CRMD achieves a -41.62% return, which is significantly lower than PLTR's -17.70% return.

CRMD

• 1D: 3.35%
• 1M: -4.77%
• YTD: -41.62%
• 6M: -41.62%
• 1Y: 10.23%
• 3Y*: 17.93%
• 5Y*: -7.62%
• 10Y*: -8.38%

PLTR

• 1D: 6.35%
• 1M: 6.63%
• YTD: -17.70%
• 6M: -19.81%
• 1Y: 73.32%
• 3Y*: 158.69%
• 5Y*: 44.69%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CRMD vs. PLTR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRMD

CRMD Risk / Return Rank: 46
CRMD Sharpe Ratio Rank: 46
CRMD Sortino Ratio Rank: 49
CRMD Omega Ratio Rank: 51
CRMD Calmar Ratio Rank: 42
CRMD Martin Ratio Rank: 42

PLTR

PLTR Risk / Return Rank: 77
PLTR Sharpe Ratio Rank: 81
PLTR Sortino Ratio Rank: 76
PLTR Omega Ratio Rank: 75
PLTR Calmar Ratio Rank: 76
PLTR Martin Ratio Rank: 76

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRMD vs. PLTR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and Palantir Technologies Inc. (PLTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRMD	PLTR	Difference
Sharpe ratio Return per unit of total volatility	0.14	1.28	-1.14
Sortino ratio Return per unit of downside risk	0.74	1.85	-1.10
Omega ratio Gain probability vs. loss probability	1.11	1.24	-0.13
Calmar ratio Return relative to maximum drawdown	0.01	1.86	-1.85
Martin ratio Return relative to average drawdown	0.02	4.55	-4.53
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRMD vs. PLTR - Sharpe Ratio Comparison

The current CRMD Sharpe Ratio is 0.14, which is lower than the PLTR Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of CRMD and PLTR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	CRMD	PLTR	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.14	1.28	-1.14
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.10	0.69	-0.78
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.09	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.05	0.92	-0.97

Correlation

The correlation between CRMD and PLTR is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CRMD vs. PLTR - Dividend Comparison

Neither CRMD nor PLTR has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

CRMD vs. PLTR - Drawdown Comparison

The maximum CRMD drawdown since its inception was -98.28%, which is greater than PLTR's maximum drawdown of -84.62%. Use the drawdown chart below to compare losses from any high point for CRMD and PLTR.

Drawdown Indicators

	CRMD	PLTR	Difference
Max Drawdown Largest peak-to-trough decline	-98.28%	-84.62%	-13.66%
Max Drawdown (1Y) Largest decline over 1 year	-62.26%	-37.81%	-24.45%
Max Drawdown (5Y) Largest decline over 5 years	-72.94%	-79.14%	+6.20%
Max Drawdown (10Y) Largest decline over 10 years	-96.22%	—	—
Current Drawdown Current decline from peak	-86.24%	-29.39%	-56.85%
Average Drawdown Average peak-to-trough decline	-76.90%	-40.57%	-36.33%
Ulcer Index Depth and duration of drawdowns from previous peaks	35.29%	15.48%	+19.81%

Volatility

CRMD vs. PLTR - Volatility Comparison

CorMedix Inc. (CRMD) has a higher volatility of 16.11% compared to Palantir Technologies Inc. (PLTR) at 14.75%. This indicates that CRMD's price experiences larger fluctuations and is considered to be riskier than PLTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRMD	PLTR	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.11%	14.75%	+1.36%
Volatility (6M) Calculated over the trailing 6-month period	56.16%	37.73%	+18.43%
Volatility (1Y) Calculated over the trailing 1-year period	75.19%	57.68%	+17.51%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	78.08%	65.50%	+12.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	92.46%	70.22%	+22.24%

Financials

CRMD vs. PLTR - Profitability Comparison

The chart below illustrates the profitability comparison between CorMedix Inc. and Palantir Technologies Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

CRMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, CorMedix Inc. reported a gross profit of 107.31M and revenue of 128.62M. Therefore, the gross margin over that period was 83.4%.

PLTR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Palantir Technologies Inc. reported a gross profit of 1.19B and revenue of 1.41B. Therefore, the gross margin over that period was 84.7%.

CRMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, CorMedix Inc. reported an operating income of 59.13M and revenue of 128.62M, resulting in an operating margin of 46.0%.

PLTR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Palantir Technologies Inc. reported an operating income of 575.39M and revenue of 1.41B, resulting in an operating margin of 40.9%.

CRMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, CorMedix Inc. reported a net income of 14.02M and revenue of 128.62M, resulting in a net margin of 10.9%.

PLTR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Palantir Technologies Inc. reported a net income of 608.68M and revenue of 1.41B, resulting in a net margin of 43.3%.